文献速递复苏、休克与脓毒症

氢气吸入抑制大鼠严重出血后向「不可逆」休克阶段的进展

Hydrogen gas inhalation inhibits progression to the "irreversible" stage of shock after severe hemorrhage in rats.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论大鼠失血性休克模型中,吸入1.3%氢气混合气可提高6小时生存率(80% vs 30%)并延迟向不可逆休克进展,作者认为可能用于稳定患者直至根治性治疗。

研究在大鼠中通过放血至平均动脉压30-35 mm Hg并维持休克60分钟、随后以四倍失血量生理盐水复苏建立失血性休克模型。大鼠分为氢气组(1.3%氢气、26%氧气、72.7%氮气)与对照组(26%氧气、74%氮气),从开始放血时吸入并持续至液体复苏后2小时。液体复苏后6小时生存率氢气组80%、对照组30%(p<0.05)。氢气组诱导休克所需放血量更大、休克60分钟后血钾升高受抑制、复苏后血压完全恢复且代谢性酸中毒代偿良好。作者结论认为氢气吸入延迟向不可逆休克进展,临床上预期可稳定患者直至根治性治疗。

要点

  • 大鼠失血性休克模型中,液体复苏后6小时生存率氢气组80% vs 对照组30%(p<0.05)。
  • 氢气组诱导休克所需放血量显著大于对照组,但休克60分钟后血钾升高仍受抑制。
  • 液体复苏后氢气组血压完全恢复,对照组未能完全恢复;复苏后2小时氢气组血压维持正常范围且代谢性酸中毒代偿良好。
  • 对照组存活大鼠在复苏后2小时出现血压下降、未代偿的代谢性酸中毒和高钾血症。
  • 作者认为氢气吸入可稳定患者直至根治性治疗,从而提高失血性休克后的生存概率。

适用人群与场景

  • 大鼠失血性休克模型:放血至平均动脉压30-35 mm Hg,维持休克60分钟后以四倍失血量生理盐水复苏。

诊断标准与关键阈值

  • 以平均动脉压降至30-35 mm Hg作为失血性休克模型目标。

处置流程与药物剂量

  • 氢气组吸入1.3%氢气、26%氧气、72.7%氮气混合气,从开始放血时启动,持续至液体复苏后2小时。
  • 对照组吸入26%氧气、74%氮气混合气,时间方案同氢气组。
  • 休克60分钟后以生理盐水复苏,容量为失血量的四倍。

研究设计与关键结果

  • 研究类型为大鼠实验;液体复苏后6小时生存率氢气组80% vs 对照组30%(p<0.05)。
  • 氢气组诱导休克所需放血量显著大于对照组。
  • 休克60分钟后氢气组血钾升高受抑制。
  • 液体复苏后氢气组血压完全恢复,对照组血压未完全恢复。
  • 复苏后2小时氢气组血压维持正常范围、代谢性酸中毒代偿良好;对照组存活大鼠出现血压下降、未代偿的代谢性酸中毒和高钾血症。

证据类型、等级与局限

  • 证据类型:大鼠实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,氢气吸入可稳定患者直至根治性治疗,从而提高失血性休克后的生存概率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Mortality of hemorrhagic shock primarily depends on whether or not the patients can endure the loss of circulating volume until radical treatment is applied. We investigated whether hydrogen (H2) gas inhalation would influence the tolerance to hemorrhagic shock and improve survival.

METHODS: Hemorrhagic shock was achieved by withdrawing blood until the mean arterial blood pressure reached 30-35 mm Hg. After 60 minutes of shock, the rats were resuscitated with a volume of normal saline equal to four times the volume of shed blood. The rats were assigned to either the H2 gas (1.3% H2, 26% O2, 72.7% N2)-treated group or the control gas (26% O2, 74% N2)-treated group. Inhalation of the specified gas mixture began at the initiation of blood withdrawal and continued for 2 hours after fluid resuscitation.

RESULTS: The survival rate at 6 hours after fluid resuscitation was 80% in H2 gas-treated rats and 30% in control gas-treated rats (p < 0.05). The volume of blood that was removed through a catheter to induce shock was significantly larger in the H2 gas-treated rats than in the control rats. Despite losing more blood, the increase in serum potassium levels was suppressed in the H2 gas-treated rats after 60 minutes of shock. Fluid resuscitation completely restored blood pressure in the H2 gas-treated rats, whereas it failed to fully restore the blood pressure in the control gas-treated rats. At 2 hours after fluid resuscitation, blood pressure remained in the normal range and metabolic acidosis was well compensated in the H2 gas-treated rats, whereas we observed decreased blood pressure and uncompensated metabolic acidosis and hyperkalemia in the surviving control gas-treated rats.

CONCLUSIONS: H2 gas inhalation delays the progression to irreversible shock. Clinically, H2 gas inhalation is expected to stabilize the subject until curative treatment can be performed, thereby increasing the probability of survival after hemorrhagic shock.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Matsuoka T, Suzuki M, Sano M, et al. Hydrogen gas inhalation inhibits progression to the "irreversible" stage of shock after severe hemorrhage in rats. J Trauma Acute Care Surg. 2017. PMID: 28640781. doi:10.1097/TA.0000000000001620

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。